← Back to Search

Contingency Management for Smoking Cessation

N/A

Waitlist Available

Led By Ian Ayres, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 days following intake date, as well as 1 month and 6 months after intake date

Awards & highlights

Study Summary

This trial tests a new way to help people stick to a smoking cessation program. The treatment offers subjects the chance to forego a monetary incentive in exchange for abstaining from smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 days following intake date, as well as 1 month and 6 months after intake date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 days following intake date, as well as 1 month and 6 months after intake date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days following intake date, as well as 1 month and 6 months after intake date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Breath Carbon Monoxide Test (measured in ppm levels)

Maximum number of consecutive abstinent days

Proportion of CO (CO ≤ 4ppm)

Secondary outcome measures

Attrition

Contingency Management Payment

Reduced smoking

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Contingency ManagementExperimental Treatment1 Intervention

The treatment group will receive a onetime offer of $80 (a reactive carrot) to forego all abstinence (contingency management) reward payments in the future.

Group II: ControlPlacebo Group1 Intervention

The control group will receive contingency management payments and other monetary benefits for completing the trial.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Contingency Management

2003

Completed Phase 2

~3220

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,737,581 Total Patients Enrolled

Ian Ayres, PhDPrincipal InvestigatorYale Law School

Giuseppe Mattiacci, PhDPrincipal InvestigatorUniversity of Amsterdam

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities available to join this research initiative?

"Data from clinicaltrials.gov confirms that this medical study is currently accepting patients, with the initial posting having taken place on October 13th 2021 and a subsequent edit made not long ago (October 7th 2022)."

Answered by AI

What is the primary objective of this clinical investigation?

"The primary purpose of this trial, estimated to last 14 days from the intake date, is to measure Breath Carbon Monoxide Test (ppm levels). Secondary objectives include Reduced Smoking - quantified by reported changes in smoking habits; Contingency Management Payments - evaluated via total abstention rewards administered; and Time to First Relapse – documented through self-reported use of nicotine products or cigarette alternatives."

Answered by AI

How many individuals are currently participating in this clinical experiment?

"Affirmative, clinicaltrials.gov data shows that this trial is actively searching for participants. It was first posted on October 13th 2021 and last updated on October 7th 2022, with a goal of recruiting 200 people from one particular location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Preliminary Test of Reactive Carrot Incentives in a Practice Quit Environment With Contingency Management Incentives

2021. "Preliminary Test of Reactive Carrot Incentives in a Practice Quit Environment With Contingency Management Incentives". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05072301.